In the News: US Lawmakers Seek Increased Scrutiny of US Clinical Drug Trials in China; China Eases Foreign Investment Rules; and Wealth Connect Scheme Expanded

U.S. lawmakers call on the government to scrutinize drugmakers' clinical trials in China; China removes restrictions for foreign investments in the manufacturing and services industries; and Cross-Boundary Wealth Connect gains 10 new additional securities firms for increased offshore investment opportunities.